pharmacy compounded semaglutide for Women FDA Warns Against Compounded Semaglutide
Description
Despite the therapeutic success, currently available GLP-1R agonists are suboptimal due to poor patient compliance caused by subcutaneous injections and several side-effects such as nausea and vomiting 4,5
Providers may decline treatment for any clinical reason
During GLP-1 use, especially for weight reduction, appetite is regulated: food moves through the stomach more slowly, fullness signals last longer, and hunger hormones are controlled
Do not let logistics make it higher
To find out which medicine, or combination of medications, is most appropriate for their unique medical needs and lifestyle, patients should speak with their healthcare providers
